In November 2016, a company located in California, Cannabis Technology, released its “pain patch” which can be utilized for transdermal delivery of medical cannabis.
As more says nationwide legislate for the legalization of cannabis and cannabis-derived medications, we at Cannabis Science are centered on developing pharmaceutical formulations and applications to provide the huge developing demand expected in the coming few years.
An additional non-psychoactive cannabinoid, beta-caryophyllene, includes a unique molecular structure than almost every other cannabinoids, and it relieves inflammation and inhibits neural discomfort reception. Opioids are extremely addictive and pose a threat of overdosing, and this issue is becoming an epidemic in the US.
Fibromyalgia as a dangerous neurological disorder, seen as intense musculoskeletal pain, feeling swings, fatigue, and memory and sleep issues.
Terpenes are other elements of cannabis, that offer potent pain-relieving properties.”
Generally, it’s treated with antidepressants, prescription discomfort relievers, acetaminophen, and anti-seizure meds. is that the patch offers a managed release of the remedy into the patient, generally through the porous membrane covering a reservoir of drug or through body temperature melting slim layers of medication inserted in the adhesive which is including high potency cannabinoid (CBD) extract that gradually enters in to the bloodstream and penetrates the central nervous system of the sufferer delivering the pain alleviation sought. Both terpenes and cannabinoids possess analgesic and anti-inflammatory properties, and these phytochemicals can be quickly metabolized in our bodies. It is promoted in an effort to soothe neuropathy discomfort and fibromyalgia, and when put on the area, the skin absorbs cannabis and enters the bloodstream quickly. Cannabinoids also reduce inflammation and improve the Patients who have applied it reported a 64 percent decrease in their use of the conventional prescription pain medications, which also resulted in fewer side-effects.”
The transdermal medical cannabis patches and transdermal pens are available in Mary’s Medicinal in Oregon, Colorado, Nevada, Michigan, Washington, and Arizona.
The CEO, Mr. Raymond C. Dabney adds:
“The development of these two new pharmaceutical medicinal applications is merely the end of the iceberg for what we see because the future for Cannabis Research.Numerous scientific tests have verified the miraculous ramifications of cannabis, so its restrictions are being decreased to an excellent extent now”.
Most experts concur that medical marijuana is way better than ibuprofen, and a research confirmed that it resulted in improvements with regards to their discomfort, function, cognitive function and general quality of life.
The company said:
“Promote healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive which will be containing high potency cannabinoid (CBD) extract that slowly enters into the bloodstream and then penetrates the central nervous system of the patient delivering the pain relief sought.”
The patch includes a higher potency cannabinoid (CBD) extract, that gradually gets into the blood vessels and penetrates the central nervous system.
While we make an effort to increase our land capacity for development and facilities to create our own product to supply our experts with proprietary components to produce these formulations, we have been also busy researching more potential requirements for Cannabis related medical applications and expanding the techniques for delivery of the medications.
The legalization of medical marijuana in the us decreased that number overdose deaths by 25%, as 30% of Americans have problems with chronic pain.
Experts at the University of Michigan discovered that the usage of medical cannabis can easily manage chronic pain.
Research have found that cannabidiol (CBD) from cannabis enters the bloodstream, attaches to the cannabinoid receptors in the peripheral nerves quickly, and blocks the discomfort indicators before they reach the brain.
There are identified more than 85 cannabinoids, and our nervous and digestive tract have their endocannabinoid receptors, which play an essential role inside our body, regulating appetite, movements, sleep, and emotions.
The National Pain Foundations made a report in 2014 which showed that marijuana helped 62% of fibromyalgia patients treat the pain and other symptoms.